Board of Directors

Top leaders from academia, government, and industry, representing a variety of biotech disciplines, serve on Bio Nebraska’s Board of Directors.

Current Directors

Josh Johnson, Chairman

Director of Biologics Operations, Huvepharma

Ronnie Green, Ph.D.

Chancellor, University of Nebraska-Lincoln

Christopher Kratochvil, M.D.

Associate Vice Chancellor, University of Nebraska Medical Center

Todd Sneller

Sneller Associates

Tyler Martin, M.D.

CEO, Adjuvance Technologies

Gary Madsen, Ph.D.

CEO, ProTransit Nanotherapy

Michael Dixon, Ph.D.

President and CEO, UNeMed Corporation

Kyle Nixon

General Manager, Novozymes

Lyle Middendorf

Sr. VP and Chief Technical Officer, LI-COR Biosciences

Charles Bicak, Ph.D.

Senior Vice Chancellor, University of Nebraska at Kearney 

Rachel Hurley

Midwest Government Affairs Manager, Bayer Crop Science

Matthew Kreifels

Vice President of Sales, Streck Inc.

Executive Leadership

Rob Owen

Executive Director

Sasha Forsen

Assistant Director